文献速递药疹与重症皮肤不良反应

台湾Stevens-Johnson综合征/中毒性表皮坏死松解症的终生风险、预期寿命、寿命损失及终生医疗支出:2008至2019年全国队列随访

Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019.
PubMed 文献 · Br J Dermatol · 2023-01-01

基于台湾全民健康保险研究数据库2008至2019年6552例新发SJS/TEN病例,量化其终生负担。患者确诊后预期寿命平均损失9.43(标准误1.06)年,男性寿命损失和年医疗支出高于女性,年轻患者预期寿命更长但寿命损失更大、终生医疗支出更高。

要点

  • SJS/TEN患者确诊后预期寿命平均损失9.43(标准误1.06)年。
  • 男性患者寿命损失[10.74(1.22)年 vs. 7.69(1.43)年]和年医疗支出高于女性。
  • 诊断时入住ICU、恶性肿瘤、糖尿病、终末期肾病及SJS/TEN相关后遗症患者寿命损失和每生命年医疗支出更大。

核心结论

  • 与一般人群相比,SJS/TEN患者承受显著的预期寿命损失和医疗支出,尤其是年轻患者。

研究设计与样本

  • 基于台湾全民健康保险研究数据库和生命统计寿命表,2008至2019年全国队列研究,纳入6552例新发SJS/TEN病例。

主要发现

  • 2008至2019年间SJS/TEN累积发病率呈下降趋势。
  • 与一般人群相比,SJS/TEN患者确诊后预期寿命平均损失9.43(标准误1.06)年。
  • 男性SJS/TEN患者寿命损失[10.74(1.22)年 vs. 7.69(1.43)年]和年医疗支出高于女性。
  • 诊断时年龄越轻,预期寿命越长,但寿命损失越大、终生医疗支出越高。
  • 诊断时入住ICU、恶性肿瘤、糖尿病、终末期肾病及SJS/TEN相关后遗症患者寿命损失和每生命年医疗支出显著更大。

关键数值与推荐

  • SJS/TEN患者预期寿命平均损失9.43(标准误1.06)年。
  • 男性SJS/TEN患者寿命损失10.74(1.22)年 vs. 女性7.69(1.43)年。

临床怎么用

  • 这些数据为SJS/TEN终生负担提供参考估计,帮助卫生当局评估未来预防和治疗策略的成本效益以减轻SJS/TEN负担。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) not only cause acute, devastating mucocutaneous reactions but also have long-lasting implications on survivors' lives. OBJECTIVES: To quantify the lifetime burden of SJS/TEN. METHODS: The cumulative incidence rate (CIR), life expectancy (LE), loss-of-life expectancy (LoLE) and lifetime healthcare expenditure (HE) for SJS/TEN were estimated over the period from 2008 to 2019 using data from the National Health Insurance Research Database of Taiwan and life tables of vital statistics. RESULTS: In this nationwide cohort of 6552 incident SJS/TEN cases, a trend towards a decrease in the CIR was observed between 2008 and 2019. Compared with the general population, patients with SJS/TEN experience a tremendous loss of 9.43 (1.06) [mean (SEM)] years of LE after diagnosis of SJS/TEN. Male patients with SJS/TEN had higher LoLE [10.74 (1.22) vs. 7.69 (1.43) years] and annual HE than females. Younger age at diagnosis of SJS/TEN was associated with longer LE but greater LoLE and higher lifetime HE. Patients with intensive care unit admission on diagnosis, malignancy, diabetes mellitus, end-stage renal disease and SJS/TEN-associated sequelae experienced substantially greater LoLE and HE per life year. CONCLUSIONS: Patients with SJS/TEN suffer substantial loss-of-LE and HE, particularly young patients, compared with the general population. These data provide a reference estimate of the lifetime burden of SJS/TEN to help health authorities evaluate the cost-effectiveness of future preventive and treatment strategies to minimize the burden of SJS/TEN.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chiu YM, Chiu HY. Lifetime risk, life expectancy, loss-of-life expectancy and lifetime healthcare expenditure for Stevens-Johnson syndrome/toxic epidermal necrolysis in Taiwan: follow-up of a nationwide cohort from 2008 to 2019. Br J Dermatol. 2023. PMID: 37427802. doi:10.1093/bjd/ljad234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。